Congratulations to Sanofi Framingham, FOYA Winner for Facility of the Future

Sanofi has been a pioneer in continuous biologics processing with breakthroughs in process development that have demonstrated remarkable levels of process intensification over traditional manufacturing processes. This has enabled dramatic reduction in process scale and opened a window for flexible single use technologies and the commercialization of the first Integrated Continuous Biomanufacturing (ICB) facility.

The Digitally Enabled Integrated Continuous Biomanufacturing Facility in Framingham is designed to take advantage of the advances in the Sanofi process and manufacturing technology. The project creates a highly flexible modular facility that builds on widespread disposable technology to provide a platform to produce current products and ultimately a wide range of product modalities. However, Sanofi’s ambitions did not stop there. They set out to challenge themselves to go further, integrating a true cutting-edge level of Factory 4.0 and lean manufacturing principles right from the outset of the project and have achieved a facility with higher capacity in a smaller footprint than traditionally achievable.

Congratulations are also in order for the project’s supply partners and key participants, many of them local, who partnered with Sanofi to bring the project to fruition:

Engineer/Architect (A&E)

• Jacobs Engineering

Construction Managers 

• Skanska USA
• The Cardinal Group

Main/General Contractors 

• Skanska USA
• The Cardinal Group

HVAC Subcontractors 

• CP Blouin
• Worcester Air Conditioning

Automation and Control Suppliers  

• Zenith Technologies
• Honeywell

Major Equipment Suppliers/Contractors – 

• BioPharm Engineered Systems
• EMD Millipore
• Thermo Fisher
• Cotter Brothers
• GE Healthcare

To read the full details, click here.